Lilly’s Insulin Inhaler Ain’t No Exubera
1 CommentBy Ed Silverman // September 26th, 2007 // 9:04 am
Take a look, folks. The drugmaker’s inhaled insulin gizmo is about the size of some cell phones or an iPod, which means it can be used so much more discreetly than Pfizer’s bong. Despite a new sales and advertising push, Exubera isn’t expected to survive, not after racking up measly sales. In fact, some people are now using the Pfizer device as a birdfeeder. Are Christmas ornaments next?
Of course, safety and effectiveness must still be established, given concerns over the affect on the lungs. A late-stage trial is slated to wrap in time for the firm to submit the product in 2009. Naturally, Bryce Carmine, Lilly’s global brand director told the UBS Global Life Sciences Conference, that he’s “encouraged” by the safety of inhaled insuling, according to Medical Marketing & Media.
And why shouldn’t he be encouraged? If nothing else, the Lilly device is unlikely to show up in head shops.
Michele Eichhorst
For your files